Stable reliability BURg Translations has a long-standing presence since 1936 with ISO 9001:2015 and ISO 17100:2015 certifications, indicating a reliable partner for regulated industries such as life sciences and pharmaceuticals. This positions them well for RFPs requiring quality standards and proven process maturity.

Life sciences focus Industry concentration in life sciences, medical devices, hospitals, and pharmaceuticals suggests ongoing demand for specialized, compliant localization and interpretation services, creating upsell opportunities for end-to-end global regulatory language needs.

Leadership transition Recent leadership shift with Brenda Stoltz becoming CEO in 2022 after serving as COO signals potential strategic changes and renewed growth initiatives which could open opportunities in expanded service offerings, client acquisition, and process optimization.

Tech stack fit Utilization of AWS, Salesforce, HubSpot and other tools indicates a modern tech-enabled operation with scalable workflows, offering cross-sell of integrated technology-enabled localization solutions and CRM-driven account management for larger clients.

Growth potential Revenue in the multi‑million range and a mid-sized employee base imply room to expand within existing accounts and capture mid-market deals, particularly by highlighting ISO certifications, speed-to-market, and industry-specialized translation and interpretation services.